Spesolimab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 211 publications

Successful use of spesolimab in refractory pyoderma gangrenosum.

Successful use of spesolimab in refractory pyoderma gangrenosum.

Journal: JAAD case reports

Published: March 20, 2026

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

A case of delayed-onset postoperative pyoderma gangrenosum complicated with chronic myelomonocytic leukemia treated with systemic corticosteroids and spesolimab.

Journal: JAAD case reports

Published: March 02, 2026

Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds.

Subcutaneous Spesolimab for Amicrobial Pustulosis of the Folds.

Journal: International journal of dermatology

Published: February 25, 2026

Correction to "Successful Treatment With Spesolimab in a Haemodialysis Patient With Acutely Flaring Generalised Pustular Psoriasis".

Correction to "Successful Treatment With Spesolimab in a Haemodialysis Patient With Acutely Flaring Generalised Pustular Psoriasis".

Journal: JEADV clinical practice

Published: February 25, 2026

Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies.

Generalized Pustular Psoriasis: Current Treatment and Innovative Therapies.

Journal: Cureus

Published: February 09, 2026

Role and clinical significance of PD-L1+ neutrophils in generalized pustular psoriasis

Role and clinical significance of PD-L1+ neutrophils in generalized pustular psoriasis

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: February 01, 2026

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis.

Targeting the IL-36 Pathway: Spesolimab as a Therapeutic for Acute Flares of Pustular Psoriasis.

Journal: Cureus

Published: January 23, 2026

The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.

The Relative Efficacy of Monotherapies for Palmoplantar Pustulosis and Palmoplantar Psoriasis: A Network Meta-Analysis Study of the Palmoplantar Spectrum.

Journal: Medicina (Kaunas, Lithuania)

Published: January 19, 2026

Sustained efficacy of spesolimab following flare-up dose in achieving long-term skin clearance in generalized pustular psoriasis: A case report and review of literature.

Sustained efficacy of spesolimab following flare-up dose in achieving long-term skin clearance in generalized pustular psoriasis: A case report and review of literature.

Journal: JAAD case reports

Published: January 15, 2026

The IL-36 Cytokine Rheostat: Hierarchical Regulation of Epithelial-Immune Crosstalk and Precision Therapy in Psoriatic and Related Dermatoses.

The IL-36 Cytokine Rheostat: Hierarchical Regulation of Epithelial-Immune Crosstalk and Precision Therapy in Psoriatic and Related Dermatoses.

Journal: Clinical, cosmetic and investigational dermatology

Published: January 13, 2026

Annular generalized pustular psoriasis successfully managed with spesolimab induction and secukinumab maintenance.

Annular generalized pustular psoriasis successfully managed with spesolimab induction and secukinumab maintenance.

Journal: Medicina clinica

Published: December 14, 2025

Acute Generalized Exanthematous Pustulosis: An Integrated Study of 503 Cases with Emphasis on Drug Culprits, Clinical Features, Diagnosis and Treatment.

Acute Generalized Exanthematous Pustulosis: An Integrated Study of 503 Cases with Emphasis on Drug Culprits, Clinical Features, Diagnosis and Treatment.

Journal: Journal of inflammation research

Published: December 02, 2025

Showing 1-12 of 211

Last Updated: 04/28/2026